Laddar...
Retained products of conception in hysteroscopy in a patient with breast cancer on tamoxifen
Tamoxifen is a selective oestrogen receptor modulator widely used in breast cancer treatment, with good survival rates. Its partial agonist action on other tissues such as the uterus, however, promotes the development of endometrial hyperplasia and cancer. It appears that tamoxifen does not alter th...
Sparad:
| I publikationen: | BMJ Case Rep |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BMJ Publishing Group
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6721742/ https://ncbi.nlm.nih.gov/pubmed/31473640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-230635 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|